| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/22/2001 | WO2000054034A3 Method for determining the wood/bark ratio from a flow of wood material |
| 02/22/2001 | WO2000043521A3 Endogenetic nucleic fragment associated with an autoimmune disease, marking method and reagent |
| 02/22/2001 | WO2000040614A3 Characterization of the soc/crac calcium channel protein family |
| 02/22/2001 | WO2000036107A3 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 02/22/2001 | WO2000023100A8 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 02/22/2001 | WO2000022131A3 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 02/22/2001 | WO2000022094A3 Methods for inhibiting oxidative modification of proteins |
| 02/22/2001 | WO2000013002A3 Reagentless analysis of biological samples |
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 02/22/2001 | WO1999063992A8 Novel calcium channel drugs and uses |
| 02/22/2001 | WO1999047553A3 Bacterial yeal family members as targets for antimicrobial drug design |
| 02/22/2001 | DE19960760A1 Wasserlösliche Azofarbstoffe und ihre Synthese und Verwendung Water-soluble azo dyes and their synthesis and use |
| 02/22/2001 | DE19939711A1 Verfahren und Vorrichtung zur Detektierung von Fremdkörpern in einem längsbewegten Faden Method and device for detecting foreign bodies in a longitudinally moving thread |
| 02/22/2001 | DE19939578A1 New nucleic acid encoding hemocyanin, useful for gene therapy of tumors and for recombinant production of fusion proteins for vaccination |
| 02/22/2001 | DE19938989A1 Verfahren und Vorrichtung zum Ermitteln der Qualität der Oberflächenstruktur von Häuten Method and device for determining the quality of the surface structure of skins |
| 02/22/2001 | DE19938580A1 Sensor und Verfahren zur Bestimmung des Magnesiumgehaltes einer Gusseisenschmelze Sensor and method for the determination of magnesium content of the molten cast iron |
| 02/22/2001 | DE19938520A1 Verfahren zur Qualitätskontrolle der Endothelauskleidung nativer Blutgefäße oder im Gewebelabor endothelialisierter, künstlicher oder natürlicher Blutgefäße und Blutgefäßklappen, Herzhöhlen und Herzklappen A method for quality control of the endothelial lining of native blood vessels or tissue laboratory endothelialisierter, artificial or natural blood vessels and blood vessel valves, cardiac cavities and heart valves |
| 02/22/2001 | DE19935047A1 Flow-cytometric analysis of leukocyte subpopulations, comprises combining fluorescence-labeled components with a cell system and detecting in a single batch through fluorescence-induced label reactions |
| 02/22/2001 | DE19903576C2 Quantitative Bestimmung von Analyten in einem heterogenen System Quantitative determination of analyte in a heterogeneous system |
| 02/22/2001 | CA2689735A1 Compositions comprising modafinil for treatment of fatigue associated with multiple sclerosis |
| 02/22/2001 | CA2464845A1 Hematopoietic regulatory factors and methods of use thereof |
| 02/22/2001 | CA2386518A1 Method and device for identifying a biopolymer sequence on a solid surface |
| 02/22/2001 | CA2385487A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | CA2385475A1 18 human secreted proteins |
| 02/22/2001 | CA2385431A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2383264A1 Binary encoded sequence tags |
| 02/22/2001 | CA2382655A1 Antibodies as a cancer diagnostic |
| 02/22/2001 | CA2382251A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 02/22/2001 | CA2382205A1 Detection of isomerised epitopes in autoimmune diseases |
| 02/22/2001 | CA2382148A1 25 human secreted proteins |
| 02/22/2001 | CA2382095A1 Methods of inhibiting binding of .beta.-sheet fibril to rage and consequences thereof |
| 02/22/2001 | CA2382019A1 Isomerase proteins |
| 02/22/2001 | CA2382018A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2382015A1 Membrane associated proteins |
| 02/22/2001 | CA2381979A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | CA2381978A1 Ppar.delta. links apc to chemopreventive drugs |
| 02/22/2001 | CA2381863A1 Novel transcription factor, bp1 |
| 02/22/2001 | CA2381750A1 Microelectronic molecular descriptor array devices, methods, procedures, and formats for combinatorial selection of intermolecular ligand binding structures and for drug screening |
| 02/22/2001 | CA2381714A1 Sensor devices and analytical methods for their use |
| 02/22/2001 | CA2381706A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 02/22/2001 | CA2381700A1 Method for identifying modulating compounds of neurotransmitters |
| 02/22/2001 | CA2381495A1 Internally referenced immunoassay and test device |
| 02/22/2001 | CA2381361A1 Methods and apparatuses for stretching polymers |
| 02/22/2001 | CA2381098A1 Polymerase extension at 3' terminus of pna-dna chimera |
| 02/22/2001 | CA2380983A1 Methods for identification of compounds stimulating insulin secretion |
| 02/22/2001 | CA2380979A1 Inhibitors of the lectin complement pathway (lcp) and their use |
| 02/22/2001 | CA2380972A1 Method of using platelet contractile force and whole blood clot elastic modulus as clinical markers |
| 02/22/2001 | CA2380966A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras |
| 02/22/2001 | CA2380925A1 Ph sensor for indicating the ph of a sample, the fabrication and use thereof |
| 02/22/2001 | CA2380888A1 Treatment of metastatic disease |
| 02/22/2001 | CA2380753A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 02/22/2001 | CA2380655A1 Method for luminescence measurements |
| 02/22/2001 | CA2380652A1 Flocculation of cell material |
| 02/22/2001 | CA2380622A1 A method for predicting the presence of haemostatic dysfunction in a patient sample |
| 02/22/2001 | CA2379311A1 A large animal model of invasive pulmonary aspergillosis in an immunocompromised host |
| 02/22/2001 | CA2378717A1 Preparation of metal oxide supports loaded with biomolecules |
| 02/22/2001 | CA2378712A1 Methods for preparing perfluorinated [18f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection |
| 02/22/2001 | CA2378711A1 Method for indirectly determining the blood-clotting status |
| 02/22/2001 | CA2377662A1 Novel protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 02/21/2001 | EP1077377A2 Method and apparatus for determining the quality of the surface structure of skins |
| 02/21/2001 | EP1077375A1 Method and apparatus for measuring NOx gas concentration |
| 02/21/2001 | EP1077374A2 Sensor and method for the determination of the magnesia content of cast iorn |
| 02/21/2001 | EP1077367A1 Capacitive force gauge |
| 02/21/2001 | EP1077217A2 Neuroactive peptides and their use |
| 02/21/2001 | EP1076825A1 Diagnostic method for algic pathologies |
| 02/21/2001 | EP1076824A1 Antenatal screening for down's syndrome |
| 02/21/2001 | EP1076823A1 Light detecting optical device |
| 02/21/2001 | EP1076822A1 Method and apparatus for determining seed quality by fluorescence |
| 02/21/2001 | EP1076723A2 Use of cathepsin s in the diagnosis and treatment of endometriosis |
| 02/21/2001 | EP1076710A2 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 02/21/2001 | EP1076704A1 Il-2 selective agonists and antagonists |
| 02/21/2001 | EP1076692A2 Crystallizable jnk complexes |
| 02/21/2001 | EP1076691A1 Cellular and animal models for diseases associated with altered mitochondrial function |
| 02/21/2001 | EP1076690A2 Methods for modulating differentiation |
| 02/21/2001 | EP1076689A1 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same |
| 02/21/2001 | EP1076568A1 Non-invasive methods to detect prostate cancer |
| 02/21/2001 | EP1076560A1 Inhibition of protein kinases with piridinylimidazoles |
| 02/21/2001 | EP0784683B1 Tie-2 ligands, methods of making and uses thereof |
| 02/21/2001 | EP0755457B1 Novel Aryl-N-Alkylacridanthiocarboxylate derivatives useful for chemiluminescent detection |
| 02/21/2001 | EP0526452B1 Hybrid immunoglobulins |
| 02/21/2001 | CN2420646Y Transparent conductive glass micro reaction chamber |
| 02/21/2001 | CN1285040A Skin test for schizophrenia |
| 02/21/2001 | CN1285003A Screening appays for the detection and diagnosis of influenza virus |
| 02/21/2001 | CN1285001A Methods for simultaneous identification of novel biological targets and lead structures for drug development |
| 02/21/2001 | CN1284966A Novel G protein-coupled receptor |
| 02/21/2001 | CN1284652A Electrochemical analysis for determinating initial time of sample detection |
| 02/21/2001 | CN1284568A Disease detecting method utilizing leucocyte disserentiating antigen gene chip |
| 02/21/2001 | CN1284567A Method of detecting fluorescent signal of DNA chip based on ratio process |
| 02/21/2001 | CN1062308C Hair fillicle culture in vitro method |
| 02/20/2001 | US6192168 Reflectively coated optical waveguide and fluidics cell integration |
| 02/20/2001 | US6191421 Gas analyzer using infrared radiation to determine the concentration of a target gas in a gaseous mixture |
| 02/20/2001 | US6191418 Device for delivery of multiple liquid sample streams to a mass spectrometer |
| 02/20/2001 | US6191278 Water-soluble rhodamine dyes and conjugates thereof |
| 02/20/2001 | US6191270 Nucleotide sequences coding plasmodium protein; for prevention and immunization against plasmodium infection |
| 02/20/2001 | US6191268 Nucleotide sequence coding human maintenance protein; for the detection and treatment of tumors; for the detection of oncogenes |
| 02/20/2001 | US6191261 Immunoglobulin that preferential binds a growth factor; for the diagnosis and treatment of cell proliferative defects; antiproliferative agents |
| 02/20/2001 | US6191169 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
| 02/20/2001 | US6191108 RH blood group antigen compositions and methods of use |
| 02/20/2001 | US6191104 Methods of treating graft rejection with the IL-17 receptor |
| 02/20/2001 | US6190923 Diethylenetriamine-N,N′,N″-triacetic acid derivatives |